Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Food or edible as carrier for pharmaceutical
Patent
1997-08-22
2000-04-11
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Food or edible as carrier for pharmaceutical
514 42, 514 44, 514 45, 514554, 514663, 562512, 562553, 424439, A61K 4700
Patent
active
060485434
ABSTRACT:
A method for treating a human having elevated tumor necrosis factor levels by administrating an effective amount of one of the amino acids glycine, alanine, or serine.
REFERENCES:
patent: 4988724 (1991-01-01), Ajani et al.
patent: 4994492 (1991-02-01), Kendall, et al.
patent: 5198465 (1993-03-01), Dioguardi
patent: 5231085 (1993-07-01), Alexander et al.
patent: 5260279 (1993-11-01), Greenberg
patent: 5430064 (1995-07-01), Hirsch et al.
patent: 5462924 (1995-10-01), Kihlberg et al.
patent: 5508262 (1996-04-01), Norman, Jr.
patent: 5525629 (1996-06-01), Crimmin et al.
patent: 5571783 (1996-11-01), Montagne et al.
patent: 5576287 (1996-11-01), Zaloga et al.
patent: 5576351 (1996-11-01), Yoshimura et al.
patent: 5656608 (1997-08-01), Schneider et al.
Belokrylov, et al., Byull. Eksp. Biol. Med., vol. 102, pp 931-933, (1986).
Belokrylov, et al., Int. J. Immunopharmac, vol. 14, pp. 1285-1292 (1986).
Bennett, et al., Nephrology Dialysis Transplantation, vol. 9, pp. 141-145 (1994).
Butter, et al., Transplantation Proceedings, vol. 23, No. 5, 1991, pp. 2378-2379.
Chemical Abstract JP04091032.
Chemical Abstract JP04091033.
De Nicola, et al., J Am Soc Nephrol, vol. 2 pp. 47P (1991).
De Nicola, et al., J. Clin Invest, vol. 92 pp. 1859-1865 (1993).
Derwent Abstract No. 72-27052T Oct. 15, 1970.
Derwent Abstract No. 82-02453E Jun. 30, 1980.
Derwent Abstract No. 82-55461E Nov. 19, 1980.
Derwent Abstract No. 83-07759K Jul. 3, 1981.
Derwent Abstract No. 90-141600.
Derwent Abstract No. 92-235891.
Derwent Abstract No. 93-052862.
Derwent Abstract No. 95-268841, Apr. 7, 1993.
Garza-Quintero, et al., American Physiological Society, F1075-F1082, (1990).
Hagglund, et al., Immunobiol. vol. 188, pp. 62-69 (1993).
Heyman, et al., Kidney International, vol. 42, pp. 41-45, (1992).
Ikejima, et al., American Physiological Society, G1581-G1586, (1997).
Jain, et al., Indian Journal of Experimental Biology, vol. 27, pp. 292-293 (1989).
Kulkarni, et al., Nutrition, vol. 6, pp 66-9 (1990).
Mobb GE, Renal Fail, vol. 14, pp 175-181, (1992).
Nissim, et al., Kidney International, vol. 49, pp 684-695.
Snyder, et al., J. Pharmac. 53, 473-484, (1975).
Spittler, et al., Department of Surgery.
Stryer, L., Biochemistry.
Thurman, et al., Hepatology, vol. 24, abstract No. 1230, (1996).
Thurman, et al., Transplantation, vol. 63, pp. 1661-1667, (1997).
Toth, et al., Acta Microbiol, Hung. vol. 32, pp. 369-372 (1985).
Toth, et al., Acta Microbiol. Hung. vol. 32, pp. 363-368 (1985).
Weinberg, et al., Kidney International, vol. 52, pp. 140-151, (1997).
Yin, et al., Laboratory of Hepatobiology and Toxicology, 28 pages.
Young, et al., Kidney International, vol. 48, pp. 439-448, (1995).
Shiratori et al, Modulation of KC/GRO protein (interleukin-8 related proteins in rodents) release from hepatocytes by biologically active mediators, Biochemical and Biophysical Research Communications, vol. 203(3), 1398-1403, Sep. 30, 1994.
Remick et al, Cytokines and extrahepatic sequelae of Ischemia-Reperfusion injury to liver, Annals of New York Academy of Sciences, vol. 723, 271-283, Jun. 17, 1994.
Grimble et al, Cysteine and glycine supplemetation modulate the metabolic response to Tumor Necrosis Factor in Rats fed a low protein diet, Journal of Nutrition, 122, 2066-2073, 1992.
Fishman, M., Cytolytic activities of activated macrophage versus paraformaldehyde-fixed macrophages; soluble versus membrane-associated TNF, Cellular Immunology, 137, 164-174, 1991.
Blum, et al., Life Sciences, vol. 14, pp 557-565 (1974).
Jeevanandam, et al., The Lancet, pp. 1423-1426 (Jun. 30, 1984).
Derwent Abstract No. 93-183072/23 (1991)
Derwent Abstract No. 93-126956/16 (1991).
Derwent Abstract No. 89-286411/40 (1988).
Derwent Abstract No. 93-299541/38 (1984).
Butter, et al., Transplantation, vol. 56, pp. 817-822, No. 4, (Oct. 1993).
Weinberg, et al., American Journal of Physiology, vol. 258, pp. C1127-C1140, (1990).
Weinberg, et al., The Amer. Society for Clinical Investigation, Inc., pp. 1446-1454, vol. 80, (Nov. 1987).
Grimble, et al., J. Nutrition, vol. 122, pp. 2066-2073, (Jun. 22, 1992).
M. Schilling, et al., Transplantationsmedizin, vol. 6, pp. 140-143, (1994).
Endre, et al., Biochemical & Biophysical Res. Comm., vol. 202, No. 3, pp. 1639-1644.
Ozaki, et al., Transplantations, vol. 58, No. 6, pp. 753-755 (1994).
Pathirana et al., Journal Nutrition, No. 7, pp. 1369-1375 (Jul. 1992).
Derwent Abstract No. 50355C/29 (04.10.78).
Derwent Abstract No. 93-299541/38 (84.08.20).
Derwent Abstract No. 89-250045/35 (30.08.89).
Schneider Heinz
Thurman Ronald G.
Channavajjala Lakshmi
Morris Michael P.
Novartis Nutrition AG
Page Thurman K.
Pfeiffer Hesna J.
LandOfFree
Amino acid compositions and use thereof in clinical nutrition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amino acid compositions and use thereof in clinical nutrition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amino acid compositions and use thereof in clinical nutrition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1174593